The use of botulinum toxin in ophthalmology

Katarzyna Łysiak; Anna Łysiak; Barbara Maziarz; Paulina Przywara; Natalia Bogumiłło; Kinga Ściurka; Julia Ignacak; Mikołaj Borek

doi:10.56782/pps.253

Published : 2024-12-13

Vol. 22 No. 4 (2024)

The use of botulinum toxin in ophthalmology

Katarzyna Łysiak

Anna Łysiak

Barbara Maziarz

Paulina Przywara

Natalia Bogumiłło

Kinga Ściurka

Julia Ignacak

Mikołaj Borek

DOI: https://doi.org/10.56782/pps.253

Abstract

Botulinum toxin is an exotoxin produced by the anaerobic bacteria Clostridium botulinum. It is one of the most potent neurotoxins known and used in medicine. Its versatile use covers various fields of medicine, including ophthalmology. Botulinum toxin is widely used in ophthalmology for both therapeutic and aesthetic purposes. Thanks to its mechanism of action of inhibiting the release of acetylcholine, it leads to muscle paresis and inhibition of the function of the exocrine glands. This makes it effective in treating such conditions as, for example, strabismus, nystagmus, epiphora, and eyelid spasm. On the other hand, in aesthetic medicine it is used to reduce "crow's feet". The properties of botulinum toxin make it a beneficial therapeutic tool used in ophthalmology. Studies show its effectiveness in treating various ocular muscle dysfunctions and excessive tearing. The purpose of this article is to discuss the current indications and potential uses of botulinum toxin in ophthalmology.

Keywords:

botulinum toxin, ophthalmology, strabismus, tearing, eyelid spasm

Most read articles by the same author(s)

Katarzyna Łysiak, Anna Łysiak, The role of the gut microbiome in Alzheimer's disease , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)
Magdalena Makarewicz, Anna Łysiak, Katarzyna Łysiak, Barbara Maziarz, Evaluation of the effectiveness of platelet-rich plasma therapy in the treatment of osteoarthritis compared to other treatment methods , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)
Katarzyna Łysiak, Anna Łysiak, Barbara Maziarz, Paulina Przywara, Natalia Bogumiłło, Julia Ignacak, Kinga Ściurka, Mikołaj Borek, Oliwia Grzelak, Insomnia in the elderly and contemporary treatment methods , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)

Details

References

Statistics

Authors

Download files

PDF (Język Polski)

Citation rules

Łysiak, K., Łysiak, A., Maziarz, B., Przywara, P., Bogumiłło, N., Ściurka, K., … Borek, M. (2024). The use of botulinum toxin in ophthalmology. Prospects in Pharmaceutical Sciences, 22(4), 93–98. https://doi.org/10.56782/pps.253

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

1. Sobel, J. Botulism. Clin. Infect. Dis. 2005, 41, 1167-1173. DOI: 10.1086/444507

2. Wan, M.J.; AlShaker, S.; Hunter, D G. Use of Botulinum Toxin in Ophthalmology. Handb. Exp. Pharmacol. 2021, 263, 147-160. DOI: 10.1007/164_2019_325

3. Dressler, D.; Adib Saberi, F. Botulinum Toxin: Mechanisms of Action. Eur. Neurol. 2005, 53, 3–9. DOI: 10.1159/000083259

4. Nigam, P. K.; Nigam, A. Botulinum toxin. Indian J. Dermatol. 2010, 55, pp. 8–14. DOI: 10.4103/0019-5154.60343

5. Dutta, S.R.; Passi, D.; Singh, M.; Singh, P.; Sharma, S.; Sharma, A. Botulinum toxin the poison that heals: A brief review. Natl. J. Maxillofac. Surg. 2016, 7, 10–16. DOI: 10.4103/0975-5950.196133

6. Lam, K.H.; Jin, R. Architecture of the botulinum neurotoxin complex: a molecular machine for protection and delivery. Curr. Opin. Struct. Biol. 2015, 31, 89–95. DOI: 10.1016/j.sbi.2015.03.013

7. Montal, M. Botulinum neurotoxin: a marvel of protein design. Annu. Rev. Biochem. 2010, 79, 591-617. DOI: 10.1146/annurev.biochem.051908.125345

8. Breidenbach, M.A.; Brunger, A.T. Substrate recognition strategy for botulinum neurotoxin serotype A. Nature. 2004, 432, 925-929. DOI: 10.1038/nature03123

9. Dressler, D.; Saberi, F.A.; Barbosa, E.R. Botulinum toxin: mechanisms of action. Arq. Neuropsiquiatri. 2005, 63, 180-185. DOI: 10.1590/s0004-282x2005000100035

10. Dutton, J.J.; Fowler, A.M. Botulinum toxin in ophthalmology. Surv. Ophthalmol. 2007, 52, 13-31. DOI: 10.1016/j.survophthal.2006.10.003

11. Gregory, S.; Acharya, K.R. A Comprehensive Structural Analysis of Clostridium botulinum Neurotoxin A Cell-Binding Domain from Different Subtypes. Toxins (Basel). 2023, 15, Art. No: 92. DOI: 10.3390/toxins15020092

12. Montecucco, C.; Molgó, J. Botulinum neurotoxins: revival of an old killer. Curr. Opin. Pharmacol. 2005, 5, 274-279. DOI: 10.1016/j.coph.2004.12.006

13. Simpson, L. L. Identification of the major steps in botulinum toxin action. Ann. Rev. Pharmacol. Toxicol. 2004, 44, 167-193. DOI: 10.1146/annurev.pharmtox.44.101802.121554

14. Leszczynska, A.; Nowicka, D.; Pillunat, L.E.; Szepietowski, J.C. Five decades of the use of botulinum toxin in ophthalmology. Indian J. Ophthalmol. 2024, 72, 789-795. DOI: 10.4103/IJO.IJO_1030_23

15. Binenbaum, G.; Chang, M.Y.; Heidary, G.; Morrison, D.G.; Trivedi, R.H.; Galvin, J.A.; Pineles, S.L. Botulinum Toxin Injection for the Treatment of Strabismus: A Report by the American Academy of Ophtalmology. Ophtalmology 2021, 128, 1766-1776 DOI: 10.1016/j.ophtha.2021.05.009

16. Bort-Martí, A.R.; Rowe, F.J.; Ruiz Sifre, L.; et al. Botulinum toxin for the treatment of strabismus. Cochrane Database Syst. Rev. 2023, 3, Art. No: CD006499. DOI: 10.1002/14651858.CD006499.pub5

17. Medicine after the diploma. Available online: https://podyplomie.pl/okulistyka/38666,ortoptyka-zastosowanie-toksyny-botulinowej-i-bupiwakainy-w-leczeniu-roznych-typow-zeza?page=4&srsltid=AfmBOoru2GCUBOa_CRUVfqVqCHgmhl-vByJx4T8btQkVyFWN9TyGLf8j (accessed 07.07.2024)

18. Sabetti, L.; Guetti, F.; Pomanti, V.; Murano, G. Botulinum Toxin for the Treatment of Nystagmus Associated with Exotropia. Open J. Ophthalmol. 2022, 12, Art. No: 4. DOI: 10.4236/ojoph.2022.124036

19. Venturi, N.; Adams, G.; Theodorou, M. The Use of Botulinum Toxin in a Case of Acquired Periodic Alternating Nystagmus. Br. Ir. Orthopt. J. 2021, 17, 85-90. DOI: 10.22599/bioj.170

20. Başar, E.; Arıcı, C. Use of Botulinum Neurotoxin in Ophthalmology. Turk. J. Ophthalmol. 2016, 46, 282–290. DOI: 10.4274/tjo.57701

21. Schinwelski, M. Blepharospasm – from diagnosis to proper treatment. OphthaTherapy. 2019, 6(1), 43-50. DOI: 10.24292/01.OT.300319.07

22. Hellman, A.; Torres-Russotto, D. Botulinum toxin in the management of blepharospasm: current evidence and recent developments. Ther. Adv. Neurol. Disord. 2015, 8, 82–91. DOI: 10.1177/1756285614557475

23. Scott, A.B.; Fahn, S.; Brin, M.F. Treatment of strabismus and blepharospasm with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine (Baltimore). 2023, 102, Art. No: e32374. DOI: 10.1097/MD.0000000000032374

24. Dressler, D.; Pan, L.; Saberi, F.A. Antibody-induced failure of botulinum toxin therapy: re-start with low-antigenicity drugs offers a new treatment opportunity. J. Neural. Transm. (Vienna). 2018, 125, 1481-1486. DOI: 10.1007/s00702-018-1911-3

25. Alsuhaibani, A.H.; Eid, S.A. Botulinum toxin injection and tear production. Curr. Opin. Ophthalmol. 2018, 29, 428-433. DOI: 10.1097/ICU.0000000000000506

26. Pattanayak, S.; Sharma, P.K.; Samikhya, S.; et al. Transconjunctival botulinum toxin injection into the lacrimal gland in crocodile tears syndrome. Indian J. Ophthalmol. 2022, 70, 1339-1342. DOI: 10.4103/ijo.IJO_2909_21

27. Lima-Fontes, M.; Leuzinger-Dias, M.; Falcão-Reis, F.; Sousa, C. Injection of Botulinum Toxin A in the Lacrimal Gland for Treatment of Epiphora in Crocodile Tears Syndrome – A Case Report. Int. Med. Case Rep. J. 2022, 15, 537–542. DOI: 10.2147/IMCRJ.S379024

28. Deka, A.; Saikia, S.P. Lower lid entropion correction with botulinum toxin injection. Oman J. Ophthalmol. 2010, 3, 158–159. DOI: 10.4103/0974-620X.71909

29. Steel, D.H.; Hoh, H.B.; Harrad, R.A.; Collins, C.R. Botulinum toxin for the temporary treatment of involutional lower lid entropion: a clinical and morphological study. Eye (Lond). 1997, 11, 472-475. DOI: 10.1038/eye.1997.128

30. Carruthers, J.; Stubbs, H.A. Botulinum Toxin for Benign Essential Blepharospasm, Hemifacial Spasm and Age-Related Lower Eyelid Entropion. Can. J. Neurol. Sci. 1987, 14, 42 – 45. DOI: 10.1017/s0317167100026159

31. Rita, M.R.H.; Deepa, M.; Gitanjali, V.C.; Tinu, S.R.; et al. Lagophthalmos: An etiological lookout to frame the decision for management. Indian J. Ophthalmol. 2022, 70, 3077–3082. DOI: 10.4103/ijo.IJO_3017_21

32. Medicine after the diploma. Available online: https://podyplomie.pl/okulistyka/33990,mozliwosci-leczenia-niedomykalnosci-szpary-powiekowej-spowodowanej-utrwalonym-porazeniem-nerwu?srsltid=AfmBOoqxhV-w6y9wU2Y3YjEF9pysSSbWF7DQdra8k5dKA0LtRbkWg2Qf (accessed 10.07.2024).

33. Yücel, O.E.; Artürk, N. Botulinum toxin-A-induced protective ptosis in the treatment of lagophthalmos associated with facial paralysis. Ophthalmic Plast. Reconstr. Surg. 2012, 28, 256-260. DOI: 10.1097/IOP.0b013e31824ee702

34. Siastała, P. Methods of revitalization of the eye area with botulinum toxin from the point of view of an ophthalmologist. Aesthet. Cosmetol. 2019, 8(1), 111-115.

35. Naik, M.N.; Soparkar, Ch.Ns.; Murthy, R.; Honavar, S.G. Botulinum Toxin in Ophthalmic Plastic Surgery. Indian J. Ophthalmol. 2005, 53, 279-288. DOI: 10.4103/0301-4738.18915

36. Carruthers, A.; Carruthers, J.; De Boulle, K. Treatment of crow’s feet lines and forehead lines with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine (Baltimore). 2023, 102, Art. No: e32496. DOI: 10.1097/MD.0000000000032496